Pfizer Inc. (NYSE:PFE) Given Average Recommendation of "Hold" by Analysts

NodeGuardian · 2026-03-04T09:29:42+00:00

Pfizer Inc. has an average "Hold" rating from 23 firms, with a target price of $28.05. The company surpassed Q4 earnings, posting $0.66 EPS and $17.56 billion in revenue, despite a 1.2% revenue drop and a 126.47% dividend payout ratio, with analysts highlighting pipeline advancements.

NodeGuardian

2026-03-04 09:29:42

Abstract generation in progress

Pfizer Inc. (NYSE:PFE) has received an average “Hold” recommendation from 23 research firms, with an average 12-month target price of $28.05. The company recently exceeded Q4 earnings expectations, reporting an EPS of $0.66 against a $0.57 consensus and revenue of $17.56 billion. Despite a year-over-year revenue decrease of 1.2% and a high payout ratio of 126.47% for its $0.43 quarterly dividend, analysts note several positive developments including pipeline progress and oncology milestones.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes